Cargando…
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer
Adrenomedullin (ADM) is an angiogenic factor that has also been shown to be a mitogen and a hypoxia survival factor for tumour cells. These properties point to ADM as a potential promoter of human malignancies, but little data are available concerning the expression of ADM in human breast cancer. In...
Autores principales: | Oehler, M K, Fischer, D C, Orlowska-Volk, M, Herrle, F, Kieback, D G, Rees, M C P, Bicknell, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394432/ https://www.ncbi.nlm.nih.gov/pubmed/14612905 http://dx.doi.org/10.1038/sj.bjc.6601397 |
Ejemplares similares
-
Tamoxifen induction of angiogenic factor expression in endometrium
por: Hague, S, et al.
Publicado: (2002) -
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
por: Passalidou, E, et al.
Publicado: (2002) -
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003) -
Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer
por: Sardari Nia, P, et al.
Publicado: (2004) -
Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma
por: Sasamura, H, et al.
Publicado: (2002)